![]() |
|
|
STUDIES AVAILABLE OF FENUGREEK
Sources :- http://www.pubmedcentral.nih.gov
PMCID: PMC2581758
42.Algorithm for complementary and alternative medicine practice and research in type 2 diabetes.
Bradley R, Oberg EB, Calabrese C, Standish LJ.
Bastyr University, Kenmore, WA 98028, USA. rbradley@bastyr.edu
OBJECTIVE: To develop a model to direct the prescription of nutritional and botanical medicines in the treatment of type 2 diabetes for both clinical and research purposes. METHODS: Available literature on nutritional and botanical medicines was reviewed and categorized as follows: antioxidant/anti-inflammatory; insulin sensitizer; and beta-cell protectant/insulin secretagogue. Literature describing laboratory assessment for glycemic control, insulin resistance, and beta-cell reserve was also reviewed and a clinical decision tree was developed. RESULTS: Clinical algorithms were created to guide the use of nutritional and botanic medicines using validated laboratory measures of glycemic control, insulin sensitivity, and beta-cell reserve. Nutrient and botanic medicines with clinical trial research support include coenzyme Q10, carnitine, alpha-lipoic acid, N-acetylcysteine, vitamin D, vitamin C, vitamin E, chromium, vanadium, omega-3 fatty acids, cinnamon (Cinnamomum cassia), fenugreek (Trigonella foenum-graecum), and gymnema (Gymnema sylvestre). CONCLUSIONS: Clinical algorithms can direct supplementation in clinical practice and provide research models for clinical investigation. Algorithms also provide a framework for integration of future evidence as it becomes available. Research funding to investigate potentially beneficial practices in complementary medicine is critically important for optimal patient care and safety.
Publication Types: PMID: 17309390 [PubMed - indexed for MEDLINE]
PMID: 16672214 [PubMed - indexed for MEDLINE]
PMCID: PMC1576255
PMID: 15936223 [PubMed - indexed for MEDLINE]
PMID: 15886458 [PubMed - indexed for MEDLINE]
PMID: 15826027 [PubMed - indexed for MEDLINE]
PMID: 15784959 [PubMed - indexed for MEDLINE]
PMID: 15738612 [PubMed - indexed for MEDLINE]
PMID: 15719265 [PubMed - indexed for MEDLINE]
PMID: 15678723 [PubMed - indexed for MEDLINE]
PMID: 15646037 [PubMed - indexed for MEDLINE]
PMID: 15489252 [PubMed - indexed for MEDLINE]
PMID: 15374601 [PubMed - indexed for MEDLINE]
PMID: 15298963 [PubMed - indexed for MEDLINE]
PMID: 15291494 [PubMed - indexed for MEDLINE]
PMID: 15285785 [PubMed - indexed for MEDLINE]
PMCID: PMC514543
109.Role of selected Indian plants in management of type 2 diabetes: a review.
Saxena A, Vikram NK.
Department of Medicine, All India Institute of Medical Sciences, New Delhi, India. abhasaxena2000@yahoo.com
Type 2 diabetes has become a global epidemic. Modern medicines, despite offering a variety of effective treatment options, can have several adverse effects. Ayurveda, a science that uses herbal medicines extensively, originated in India. Of considerable interest is the adoption of Ayurveda by the mainstream medical system in some European countries (e.g., Hungary), emphasizing this modality is increasing worldwide recognition. From ancient times, some of these herbal preparations have been used in the treatment of diabetes. This paper reviews the accumulated literature for 10 Indian herbs that have antidiabetic activity and that have been scientifically tested. Few of these herbs, such as Momordica charantia, Pterocarpus marsupium, and Trigonella foenum greacum, have been reported to be beneficial for treating type 2 diabetes. Mechanisms such as the stimulating or regenerating effect on beta cells or extrapancreatic effects are proposed for the hypoglycemic action of these herbs.
Publication Types
PMID: 15165418 [PubMed - indexed for MEDLINE]
PMID: 15162361 [PubMed - indexed for MEDLINE]
PMID: 15026271 [PubMed - indexed for MEDLINE]
PMID: 14692727 [PubMed - indexed for MEDLINE]
PMID: 14595593 [PubMed - indexed for MEDLINE]
PMID: 14569407 [PubMed - indexed for MEDLINE]
PMID: 12916246 [PubMed - indexed for MEDLINE]
PMID: 12902054 [PubMed - indexed for MEDLINE]
PMID: 12889128 [PubMed - indexed for MEDLINE]
PMID: 12841630 [PubMed - indexed for MEDLINE]
PMID: 12791229 [PubMed - indexed for MEDLINE]
PMID: 12774399 [PubMed - indexed for MEDLINE]
PMID: 12774372 [PubMed - indexed for MEDLINE]
PMID: 12683221 [PubMed - indexed for MEDLINE]
PMCID: PMC166908
PMCID: PMC2478541
PMCID: PMC124126
PMCID: PMC166532
147.Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study.
Gupta A, Gupta R, Lal B.
Jaipur Diabetes and Research Centre.
OBJECTIVES: To evaluate the effects of Trigonella foenum-graecum (fenugreek) seeds on glycemic control and insulin resistance, determined by HOMA model, in mild to moderate type 2 diabetes mellitus we performed a double blind placebo controlled study. METHODS: Twenty five newly diagnosed patients with type 2 diabetes (fasting glucose < 200 mg/dl) were randomly divided into two groups. Group I (n=12) received 1 gm/day hydroalcoholic extract of fenugreek seeds and Group II (n=13) received usual care (dietary control, exercise) and placebo capsules for two months. RESULTS: At baseline both the groups were similar in anthropometric and clinical variables. Oral glucose tolerance test, lipid levels, fasting C-peptide, glycosylated haemoglobin, and HOMA-model insulin resistance were also similar at baseline. In group 1 as compared to group 2 at the end of two months, fasting blood glucose (148.3 +/- 44.1 to 119.9 +/- 25 vs. 137.5 +/- 41.1 to 113.0 +/- 36.0) and two hour postglucose blood glucose (210.6 +/- 79.0 to 181.1 +/- 69 vs. 219.9 +/- 41.0 to 241.6 +/- 43) were not different. But area under curve (AUC) of blood glucose (2375 +/- 574 vs 27597 +/- 274) as well as insulin (2492 +/- 2536 vs. 5631 +/- 2428) was significantly lower (p < 0.001). HOMA model derived insulin resistance showed a decrease in percent beta-cell secretion in group 1 as compared to group 2 (86.3 +/- 32 vs. 70.1 +/- 52) and increase in percent insulin sensitivity (112.9 +/- 67 vs 92.2 +/- 57) (p < 0.05). Serum triglycerides decreased and HDL cholesterol increased significantly in group 1 as compared to group 2 (p < 0.05). CONCLUSIONS: Adjunct use of fenugreek seeds improves glycemic control and decreases insulin resistance in mild type-2 diabetic patients. There is also a favourable effect on hypertriglyceridemia.
Publication Types: PMID: 11868855 [PubMed - indexed for MEDLINE]
PMID: 10641147 [PubMed - indexed for MEDLINE]
PMID: 10527654 [PubMed - indexed for MEDLINE]
Sources :- http://www.pubmedcentral.nih.gov